WNYUZ
No Result
View All Result
  • Home
  • Politics
  • Opinion
  • Business
  • World
  • Health
  • Entertainment
  • Tech
  • Home
  • Politics
  • Opinion
  • Business
  • World
  • Health
  • Entertainment
  • Tech
No Result
View All Result
WNYUZ
No Result
View All Result
Home News

FDA approves Moderna’s new lower-dose COVID-19 vaccine

May 31, 2025
in News
Yahoo news home
491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option.

The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It’s made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax — by refining its immune target.

The approval “adds an important new tool to help protect people at high risk of severe disease from COVID-19,” Stephane Bancel, Moderna’s CEO, said in a statement Saturday.

The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk from the coronavirus.

That’s the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax.

Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines until now, reflecting skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials.

Moderna’s existing vaccine doesn’t face those limits and has long been used for anyone ages 6 months and older. The company said it expected to offer both options this fall.

The FDA’s approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna’s existing vaccine. It found the new vaccine was safe and was at least as effective — and more by some measures — than the original shot, the company said.

The news came just days after the Trump administration canceled funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising early study results.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

The post FDA approves Moderna’s new lower-dose COVID-19 vaccine appeared first on Associated Press.

Tags: Associated PressFood and Drug AdministrationHealth Secretary Robert F. Kennedy Jr.ModernaStephane BancelvaccineYahooYahoo News
Share196Tweet123Share
Yahoo entertainment home
News

Did “The Simpsons” really kill off Marge? The answer is complicated

June 26, 2025

Key PointsThe Simpsons' season 36 finale, "Estranger Things," skips ahead to a future where Marge is the first Simpson to ...

Read more
News

Why the talk around ‘Love Island USA’ is turning explosive

June 26, 2025
News

In surprise move, RFK Jr.’s vaccine committee votes to recommend RSV shot for infants

June 26, 2025
News

Katy Perry and Orlando Bloom End Engagement, Break Up After 9 Years

June 26, 2025
News

How to get a refund

June 26, 2025
Yahoo news home

Iran’s supreme leader makes first public statement since ceasefire declared in Israel-Iran war

June 26, 2025
Yahoo news home

Kennedy-appointed CDC vaccine panel says it will scrutinize the childhood vaccine schedule

June 26, 2025
Yahoo news home

Abrego Garcia to stay in jail as lawyers spar over potential deportation

June 26, 2025

© 2025 WNyuz.com

No Result
View All Result
  • Home
  • Politics
  • Opinion
  • Business
  • World
  • Health
  • Entertainment
  • Tech

© 2025 WNyuz.com